C-RAD AB: The first C-RAD Catalyst™ systems to Denmark

9/10/2012 4:49 AM EST

C-Rad AB
Company Announcement

C-RAD AB: The first C-RAD Catalyst™ systems to Denmark

Press release 2012-09-10



The first C-RAD Catalyst™ systems to a radiation therapy clinic in Denmark

C-RAD AB with its three fully owned subsidiaries in Sweden and three
international sales companies are all active in the field of radiation therapy.
The radiation therapy clinic at the Vejle Hospital in Denmark has ordered two
C-RAD Catalyst systems to be installed at linear accelerators from Elekta. 

The Catalyst™ is a next-generation high performance tracking system based on
optical surface scanning and augmented reality through re-projection. Advanced
and highly optimized algorithms for non-rigid registration and deformable
models enable clinicians to perform a real-time assessment of patient
positioning errors before and during treatment delivery. Interfaces to major
vendors ensure a completely integrated workflow. 

To start with the Catalyst systems will be equipped with functionality for
positioning and interfaces to Elekta Mosaiq. The two systems are planned to be
installed end of 2012. 



Erik Hedlund, CEO, C-RAD AB:

”At ESTRO meetings and when demonstrating the new innovative Catalyst system at
clinics in Denmark there has been a great interest for the inter active and
patented capabilities of the system especially when positioning breast cancer
patients and for correction of posture errors. As a result C-RAD has received a
first order of two Catalyst systems from the well-known Vejle Hospital in
Denmark.” 



Bjarke Lundegaard Mortensen, Head of Medical Physics, Technical Practice, Vejle
Hospital: 

“In Vejle we think that the Catalyst systems offer a great possibility to
improve the quality of our treatment for breast cancer. For the patients that
receive radiation of the lymph nodes in the periclavicular region the position
of the arms is crusial and we think that Calatyst can contribute to an improved
patient positioning.” 



Martin Berg, Head of Medical Physiscs, Clinical Practice, Vejle Hospital:

“We have a long tradition for having great emphase on offering optimal
treatment modalities for breast cancer patients. This improvement comes perfect
in line with our decision of offering Deep Inspiration Breath Hold (DIBH)
gating technique for all our left sided breast cancer patients a few years ago.
Also for lung cancer patients we see a potential improvement, as some patients
has lymph node involvement in the periclavicular region.” 



About Vejle Hospital:

Vejle Hospital is part of the Lillebaelt Hospital group situated around the
strait of Lillebaelt. Vejle Hospital is one of the two centers offering
radiotherapy in the Region of Southern Denmark with a population 1,200,000. 

The radiotherapy facility was established in 1983 and has since then been
expanded to six linacs.Approximately 1,500 cancer patients per year receive
radiotherapy treatment at Vejle Hospital which is an Elekta reference hospital
for clinical work. 

In May 2012 Vejle Hospital together with Elekta hosted an international
conference with focus on advanced techniques in radiation therapy of breast
cancer. 



Research

  -- Bioeffect modelling for evaluation of radiotherapy treatment strategies at
     the individual patient level

  -- Diffusion weighted MRI for treatment response prediction

  -- The value of Deep Inspiration Breath Hold (DIBH) for breast cancer



Clinical focus

  -- Combined Intensity Modulated Radiation Therapy and Brachyterapy for rectal
     and anal cancer

  -- Deep Inspiration Breath Hold (DIBH) for breast cancer Radiation Therapy

  -- Image Guided Radiation Therapy (IGRT)

  -- Regional competence center for anal cancer Radiation Therapy 





For further information:

Erik Hedlund, CEO C-RAD AB, Phone +46-(0)18-66 69 31, E-Mail